Aviva’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $456K | Sell |
21,130
-13,117
| -38% | -$283K | ﹤0.01% | 812 |
|
|
2025
Q1 | $569K | Sell |
34,247
-1,636
| -5% | -$27.2K | ﹤0.01% | 762 |
|
|
2024
Q4 | $658K | Buy |
+35,883
| New | +$658K | ﹤0.01% | 657 |
|
|
2021
Q1 | – | Sell |
-30,740
| Closed | -$1.64M | – | 939 |
|
|
2020
Q4 | $1.64M | Sell |
30,740
-24,922
| -45% | -$1.33M | 0.01% | 733 |
|
|
2020
Q3 | $2.3M | Buy |
55,662
+8,240
| +17% | +$340K | 0.01% | 693 |
|
|
2020
Q2 | $2.3M | Buy |
+47,422
| New | +$2.3M | 0.01% | 690 |
|